Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Enterra Medical, Inc.

New Hope for Chronic Nausea: Enterra Medical Begins NAVIGATE Study After Gaining FDA IDE Approval and Breakthrough Device Designation
From Enterra Medical, Inc.
Via Business Wire
Enterra® II System—an Advanced Treatment for Gastroparesis—Receives FDA Approval for MR Conditional Use
From Enterra Medical, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.